Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epithelial ovarian cancer.

Follicle-stimulating hormone (FSH) and the FSH receptor contribute to tumor angiogenesis and are acknowledged risk factors for ovarian epithelial cancer (OEC). Accumulating evidence suggests that FSH can induce vascular endothelial growth factor (VEGF) and hypoxia inducible factor 1α (HIF1α) expression. We previously demonstrated that FSH induces reactive oxygen species (ROS) production and activates Nrf2 signaling. This study was performed to investigate whether FSH induces VEGF expression via a ROS-mediated Nrf2 signaling pathway. In the current study, OET cells were treated with FSH; dichlorofluorescein staining was used to determine ROS generation, western blotting was used to quantify Nrf2 expression and VEGF expression was measured using an ELISA. Nrf2 and HIF1α were knocked down using siRNAs to investigate the role of the Nrf2 and HIF1α signaling pathways in FSH-induced VEGF expression. The chromatin immunoprecipitation assay (ChIP) was used to determine HIF1α binding to the VEGF promoter. Finally, it was found that FSH induced ROS production and activated Nrf2 signaling; elimination of ROS or knockdown of Nrf2 blocked FSH-induced VEGF expression. Knockdown of Nrf2 impaired HIF1α signaling activation. Blockage of the FSH-ROS-Nrf2-HIF1α signaling pathway attenuated FSH-induced binding of HIF1α to the VEGF promoter. Collectively, this study indicates that ROS and aberrant expression of Nrf2 play an important role in FSH-induced angiogenesis in OEC, and provides insight into the mechanisms of FSH-induced VEGF expression. Elimination of ROS or inhibition of Nrf2 may represent potential therapeutic targets for the treatment of ovarian cancer.

[1]  Zhen-bo Zhang,et al.  NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones. , 2012, Oncology reports.

[2]  H. Kwon,et al.  Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species. , 2012, Biochemical and biophysical research communications.

[3]  Y. Guillaume,et al.  Reactive oxygen species and nitric oxide effect on the steroid hormone binding with serum albumin. , 2012, Journal of pharmaceutical and biomedical analysis.

[4]  M. Kwak,et al.  NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. , 2011, Cancer research.

[5]  Christina M. Birch,et al.  KPNA6 (Importin α7)-Mediated Nuclear Import of Keap1 Represses the Nrf2-Dependent Antioxidant Response , 2011, Molecular and Cellular Biology.

[6]  S. Ben-Dor,et al.  Reactive oxygen species are indispensable in ovulation , 2011, Proceedings of the National Academy of Sciences.

[7]  D. Roy,et al.  Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. , 2011, Biochimica et biophysica acta.

[8]  Donna D. Zhang,et al.  Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. , 2010, Antioxidants & redox signaling.

[9]  H. You,et al.  GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling. , 2010, Cancer letters.

[10]  A. Russo,et al.  miR‐20b modulates VEGF expression by targeting HIF‐1α and STAT3 in MCF‐7 breast cancer cells , 2010, Journal of cellular physiology.

[11]  Donna D. Zhang,et al.  Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. , 2009, Molecular cell.

[12]  Donna D. Zhang,et al.  Acetylation of Nrf2 by p300/CBP Augments Promoter-Specific DNA Binding of Nrf2 during the Antioxidant Response , 2009, Molecular and Cellular Biology.

[13]  M. Ushio-Fukai,et al.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. , 2008, Cancer letters.

[14]  Y. Huang,et al.  Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma , 2008, Cell Research.

[15]  Weimin Chen,et al.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. , 2008, Carcinogenesis.

[16]  Donna D. Zhang,et al.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. , 2007, Toxicology and applied pharmacology.

[17]  Y. Rojanasakul,et al.  Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. , 2007, Cancer research.

[18]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[19]  Xianglin Shi,et al.  Reactive oxygen species regulate insulin-induced VEGF and HIF-1α expression through the activation of p70s6K1 in human prostate cancer cells , 2007 .

[20]  Xianglin Shi,et al.  Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. , 2007, Carcinogenesis.

[21]  Xianglin Shi,et al.  Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells , 2006 .

[22]  G. Bae,et al.  Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression , 2006, Clinical Cancer Research.

[23]  Donna D. Zhang.  Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[24]  Xianglin Shi,et al.  Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. , 2006, Free radical biology & medicine.

[25]  M. Wartenberg,et al.  Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. , 2005, Antioxidants & redox signaling.

[26]  R. Alexander,et al.  Reactive oxygen species as mediators of angiogenesis signaling. Role of NAD(P)H oxidase , 2004, Molecular and Cellular Biochemistry.

[27]  K. Lounsbury,et al.  VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer. , 2003, Gynecologic oncology.

[28]  T. Finkel.  Oxidant signals and oxidative stress. , 2003, Current opinion in cell biology.

[29]  T. Nikaido,et al.  Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells. , 2002, Anticancer research.

[30]  A. Awaya,et al.  Effects of thymic hormone on reactive oxygen species-scavengers and renal function in tacrolimus-induced nephrotoxicity. , 2002, Life sciences.

[31]  Paul I. Liu,et al.  VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors , 2002, International journal of cancer.

[32]  T. Yamakawa,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Involvement of Reactive Oxygen Species in the , 2000 .

[33]  G. Wolf,et al.  Reactive Oxygen Species Stimulate p44/42 Mitogen-Activated Protein Kinase and Induce p27Kip1 Role in Angiotensin II-Mediated Hypertrophy of Proximal Tubular Cells , 2000 .

[34]  M. Ushio-Fukai,et al.  Reactive oxygen species as mediators of angiotensin II signaling , 2000, Regulatory Peptides.

[35]  A. Zeiher,et al.  Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors , 2000, Regulatory Peptides.

[36]  T. Finkel.  Redox‐dependent signal transduction , 2000, FEBS letters.

[37]  G. Wolf,et al.  Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells. , 2000, Journal of the American Society of Nephrology : JASN.

[38]  T. Yamakawa,et al.  Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. , 2000, Endocrinology.

[39]  K. Itoh,et al.  Regulatory mechanisms of cellular response to oxidative stress. , 1999, Free radical research.